Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Soleus

<< Previous

Bullboard Posts

Next >>

Comment by Mannequinon Nov 28, 2023 8:41pm

91 Views

Post# 35757680

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Soleus

Obviously you give Soleus a seat at the table. They know people. It's in their interest. And it MUST be in our interest, because it's been a complete cluster F for the past 2 years.

Lee430 wrote: This makes sense to me as obviously they need supervision, honestly I am exhausted with Thera and would simply like to see it sold for something close to a fair value.

Trogarzon wrote: They turned activist and want to create value from this wreckage. My humble opinion.